117 related articles for article (PubMed ID: 1596886)
21. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of myeloperoxidase containing blast cells in acute myelogenous leukaemia.
Advani SH; Hegde UP; Iyer RS; Gopal R; Saikia TK; Pai SK; Nair CN; Kurkure PA; Pai VR; Nadkarni KS
Indian J Med Res; 1993 Feb; 98():8-14. PubMed ID: 8388366
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of the therapeutic efficacy and prognostic factors of intensive chemotherapy in 91 patients with acute nonlymphoblastic leukemia].
Bian SG; Hao YS; Wang ZC
Zhonghua Nei Ke Za Zhi; 1990 Jan; 29(1):22-5, 60. PubMed ID: 2401166
[TBL] [Abstract][Full Text] [Related]
24. Progress and survival factors in acute non lymphocytic leukemia. A 15 year analysis.
Friedman S; Cowan DH; Nabholtz JM; Pinkerton PH; Senn JS
Nouv Rev Fr Hematol (1978); 1992; 34(3):233-7. PubMed ID: 1408734
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of GST-pi expression in diffuse large B-cell lymphomas.
Ribrag V; Koscielny S; Carpiuc I; Cebotaru C; Vande Walle H; Talbot M; Fenaux P; Bosq J
Leukemia; 2003 May; 17(5):972-7. PubMed ID: 12750712
[TBL] [Abstract][Full Text] [Related]
26. [Results of treating acute nonlymphoblastic leukaemia in adults (author's transl)].
Hossfeld DK; Faltermeier MT; Schmidt CG
Dtsch Med Wochenschr; 1979 Nov; 104(45):1595-9. PubMed ID: 498989
[TBL] [Abstract][Full Text] [Related]
27. Cytarabine and thioguanine for acute nonlymphocytic leukemia. Another look.
Saponara EJ; Rothenberg SP; Villamena D
Arch Intern Med; 1979 Nov; 139(11):1277-80. PubMed ID: 292356
[TBL] [Abstract][Full Text] [Related]
28. Molecular responses during chemotherapy in acute myeloid leukemias in predicting poor-response to standard chemotherapy.
Maha A; Cheong SK; Leong CF; Seow HF
Malays J Pathol; 2009 Dec; 31(2):81-91. PubMed ID: 20514850
[TBL] [Abstract][Full Text] [Related]
29. [The expression of glutathione s-transferase in leukemic cells and resistance to chemotherapy].
Chen XS; Li XS; Fang TL; Cai RB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):112-4. PubMed ID: 12513810
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia.
Marie JP; Zittoun R; Delmer A; Thevenin D; Suberville AM
Leukemia; 1987 Feb; 1(2):121-6. PubMed ID: 3478535
[TBL] [Abstract][Full Text] [Related]
31. Second long-term remission achieved with low-dose Ara-C in children with relapsed acute nonlymphoblastic leukemia.
Miniero R; Saracco P; Cordero di Montezemolo L; Fiandino G; Comelli A; Madon E
Pediatr Hematol Oncol; 1987; 4(3):273-6. PubMed ID: 3152932
[No Abstract] [Full Text] [Related]
32. Flow cytometric analysis of glutathione-S-transferase-pi in acute leukemia.
Tiirikainen MI; Elonen E; Syrjälä MT; Jansson SE; Krusius T
Leukemia; 1994 Jun; 8(6):978-84. PubMed ID: 7516031
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy for relapsed and resistant acute nonlymphoblastic leukemia. Effect of ATA, an amsacrine-containing regime.
Liang R; Chan TK; Todd D
Cancer Chemother Pharmacol; 1988; 21(1):68-70. PubMed ID: 3342467
[TBL] [Abstract][Full Text] [Related]
34. Results of therapy in adult acute nonlymphoblastic leukemia: experience in Jerusalem, Israel, during 1975-1982.
Naparstek E; Zajicek G; Or R; Rachmilewitz EA; Elias M; Polliack A
Acta Haematol; 1985; 73(1):11-5. PubMed ID: 3923761
[TBL] [Abstract][Full Text] [Related]
35. In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations.
Tidefelt U; Sundman-Engberg B; Rhedin AS; Paul C
Eur J Haematol; 1989 Nov; 43(5):374-84. PubMed ID: 2482193
[TBL] [Abstract][Full Text] [Related]
36. ["Small doses" of cytosar in the therapy of acute nonlymphoblastic leukemias].
Kucher RA; Isaev VG; Savchenko VG
Ter Arkh; 1992; 64(7):21-4. PubMed ID: 1440360
[No Abstract] [Full Text] [Related]
37. Treatment of resistant disease.
Schiller GJ
Leukemia; 1998 Sep; 12 Suppl 1():S20-4. PubMed ID: 9777890
[TBL] [Abstract][Full Text] [Related]
38. Monitoring the remission induction therapy of acute nonlymphoblastic leukemia by bone marrow cell culture criteria.
Bohinjec J; Zontar D; Kralj J
Leuk Res; 1985; 9(3):369-73. PubMed ID: 3999798
[TBL] [Abstract][Full Text] [Related]
39. Analysis of drug resistance-associated proteins expressions of patients with the recurrent of acute leukemia via protein microarray technology.
Zeng DF; Zhang J; Zhu LD; Kong PY; Li JP; Zhang X; Xu W; Wang JL; Pen XG; Wang P; Liu SH
Eur Rev Med Pharmacol Sci; 2014; 18(4):537-43. PubMed ID: 24615181
[TBL] [Abstract][Full Text] [Related]
40. [The therapeutic advances in adult acute nonlymphoblastic leukemia. The experience at the Hospital de Especialidades of the Centro Médico Nacional Siglo XXI].
Chávez Sánchez G; Morales Polanco M; Meillón García LA; Guillén Mariscal C; Pizzuto Chávez J
Gac Med Mex; 1992; 128(3):215-23. PubMed ID: 1302721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
